Bionime Corporation (4737.TW)
TWD 66.0
(-0.9%)
TWD 66.0
(-0.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.75 Billion | 2.21 Billion | 1.84 Billion | 1.66 Billion | 2.17 Billion | 2 Billion |
| Cost of Revenue | 1.03 Billion | 1.2 Billion | 1.06 Billion | 919.46 Million | 1.22 Billion | 1.09 Billion |
| Gross Profit | 715.65 Million | 1 Billion | 783.13 Million | 749.12 Million | 948.41 Million | 916.99 Million |
| Operating Expenses | 673.63 Million | 843.12 Million | 728.39 Million | 704.72 Million | 781.97 Million | 677.7 Million |
| Selling, General and Administrative Expenses | 486.65 Million | 641.14 Million | 540.53 Million | 456.84 Million | 526.85 Million | 476.51 Million |
| Research and Development Expenses | 242.33 Million | 201.97 Million | 187.86 Million | 247.87 Million | 255.12 Million | 201.18 Million |
| Other Expenses | - | -15.22 Million | 17.62 Million | 30.22 Million | 10.08 Million | -49.54 Million |
| Cost and Expenses | 1.76 Billion | 2.04 Billion | 1.79 Billion | 1.62 Billion | 2 Billion | 1.76 Billion |
| Operating Income | -13.33 Million | 146.71 Million | 73.07 Million | 75.94 Million | 176.53 Million | 239.29 Million |
| Interest Expense | 48.23 Million | 30.64 Million | 19.05 Million | 21.55 Million | 31.79 Million | 29.04 Million |
| Income Tax Expense | -38.4 Million | -5.33 Million | -14.74 Million | -32.4 Million | 27.85 Million | 34.07 Million |
| Earnings before Tax | -31.87 Million | 86.48 Million | 74.58 Million | 31.11 Million | 134.56 Million | 161.96 Million |
| Net Income | 6.2 Million | 91.02 Million | 87.41 Million | 62.43 Million | 106.25 Million | 128.03 Million |
| Earnings Per Share Basic | 0.10 | 1.50 | 1.46 | 1.06 | 1.85 | 2.23 |
| Earnings Per Share Diluted | 0.10 | 1.48 | 1.44 | 1.03 | 1.81 | 2.20 |
| Weighted Average Shares Outstanding | 60.75 Million | 60.53 Million | 60.07 Million | 59.17 Million | 57.49 Million | 57.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.25 Million | 61.42 Million | 60.82 Million | 60.37 Million | 58.77 Million | 58.11 Million |
| Gross Margin | 0.41 | 0.45 | 0.42 | 0.45 | 0.44 | 0.46 |
| EBIT Margin | 0.10 | 0.14 | 0.12 | 0.14 | 0.16 | 0.17 |
| Profit Margin | 0.00 | 0.04 | 0.05 | 0.04 | 0.05 | 0.06 |
| EBITDA | 179.78 Million | 270.36 Million | 248.29 Million | 216.14 Million | 330.84 Million | 342.34 Million |
| Earnings Before Tax Margin | -0.01 | 0.07 | 0.04 | 0.05 | 0.08 | 0.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 474.78 Million | 468.47 Million | 1.75 Billion | 489.65 Million | 425.14 Million | 425.64 Million |
| Cost of Revenue | 282.83 Million | 280.42 Million | 1.03 Billion | 278.76 Million | 264.7 Million | 254.2 Million |
| Gross Profit | 191.95 Million | 188.04 Million | 715.65 Million | 210.89 Million | 160.44 Million | 171.44 Million |
| Operating Expenses | 243.74 Million | 191.49 Million | 728.98 Million | 231.7 Million | 169.56 Million | 179.89 Million |
| Selling, General and Administrative Expenses | 140.43 Million | 136.5 Million | - | 146.48 Million | 111.18 Million | 132.37 Million |
| Research and Development Expenses | 103.31 Million | 54.99 Million | - | 86.37 Million | 58.38 Million | 47.51 Million |
| Other Expenses | 12.69 Million | 3.51 Million | -728.98 Million | -231.7 Million | 6.13 Million | 11.9 Million |
| Cost and Expenses | 526.57 Million | 471.92 Million | 1.76 Billion | 510.47 Million | 434.26 Million | 434.09 Million |
| Operating Income | -51.79 Million | -3.45 Million | -13.33 Million | -20.81 Million | -2.61 Million | 4.63 Million |
| Interest Expense | 14.98 Million | 14.43 Million | 48.23 Million | 14.29 Million | 12.6 Million | 11.48 Million |
| Income Tax Expense | -17.4 Million | -8.12 Million | -38.4 Million | -37.7 Million | -2.67 Million | 12.44 Million |
| Earnings before Tax | -53.04 Million | -13.09 Million | -31.87 Million | -26.39 Million | -13.04 Million | 23.13 Million |
| Net Income | -35.81 Million | -5.03 Million | 6.2 Million | 11.45 Million | -10.11 Million | 10.52 Million |
| Earnings Per Share Basic | -0.59 | -0.08 | - | 0.19 | -0.17 | 0.17 |
| Earnings Per Share Diluted | -0.59 | -0.08 | - | 0.19 | -0.17 | 0.17 |
| Weighted Average Shares Outstanding | 60.95 Million | 60.87 Million | 60.75 Million | 60.82 Million | 60.8 Million | 60.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.95 Million | 60.87 Million | 61.25 Million | 60.82 Million | 60.8 Million | 61.46 Million |
| Gross Margin | 0.40 | 0.40 | 0.41 | 0.43 | 0.38 | 0.40 |
| EBIT Margin | -0.02 | 0.08 | - | 0.06 | 0.09 | 0.11 |
| Profit Margin | -0.08 | -0.01 | 0.00 | 0.02 | -0.02 | 0.02 |
| EBITDA | -9.43 Million | 38.39 Million | - | 27.91 Million | 39.44 Million | 45.8 Million |
| Earnings Before Tax Margin | -0.11 | -0.01 | -0.01 | -0.04 | -0.01 | 0.01 |
1752
VIVC
2120
603279
6028
PD